Bo Yin

1.2k total citations
43 papers, 873 citations indexed

About

Bo Yin is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Bo Yin has authored 43 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Immunology and 12 papers in Cancer Research. Recurrent topics in Bo Yin's work include Immunotherapy and Immune Responses (6 papers), Epigenetics and DNA Methylation (6 papers) and MicroRNA in disease regulation (5 papers). Bo Yin is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Epigenetics and DNA Methylation (6 papers) and MicroRNA in disease regulation (5 papers). Bo Yin collaborates with scholars based in China, United States and Germany. Bo Yin's co-authors include Yongsheng Song, Xin Meng, Biao Wang, Bin Wu, Renge Bu, Steven M. Mooney, Jisheng Xie, Gang Liu, Xiang Fei and Robert H. Getzenberg and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Advanced Science.

In The Last Decade

Bo Yin

40 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Yin China 19 573 330 219 169 139 43 873
Susann Förster Germany 5 666 1.2× 304 0.9× 292 1.3× 204 1.2× 133 1.0× 6 940
Xin Song China 16 662 1.2× 385 1.2× 211 1.0× 120 0.7× 94 0.7× 31 921
Duc‐Hiep Bach South Korea 16 810 1.4× 494 1.5× 303 1.4× 140 0.8× 111 0.8× 21 1.2k
Xianhui Ruan China 16 647 1.1× 332 1.0× 262 1.2× 138 0.8× 101 0.7× 63 982
Haibo Han China 17 735 1.3× 510 1.5× 262 1.2× 111 0.7× 79 0.6× 42 1.0k
Zhangqian Chen China 14 700 1.2× 421 1.3× 227 1.0× 115 0.7× 107 0.8× 19 961
Zhenjia Yu China 12 415 0.7× 285 0.9× 362 1.7× 198 1.2× 212 1.5× 20 896
Ye Song China 18 776 1.4× 507 1.5× 186 0.8× 168 1.0× 83 0.6× 44 1.1k
Amber Willbanks United States 9 555 1.0× 266 0.8× 298 1.4× 111 0.7× 70 0.5× 15 851
Junhe Li China 17 560 1.0× 342 1.0× 172 0.8× 98 0.6× 74 0.5× 31 795

Countries citing papers authored by Bo Yin

Since Specialization
Citations

This map shows the geographic impact of Bo Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Yin more than expected).

Fields of papers citing papers by Bo Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Yin. The network helps show where Bo Yin may publish in the future.

Co-authorship network of co-authors of Bo Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Yin. A scholar is included among the top collaborators of Bo Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Yin. Bo Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yin, Bo, Jie Liu, Haoran Hu, et al.. (2025). Exosomal CMTM4 Induces Immunosuppressive Macrophages to Promote Ovarian Cancer Progression and Attenuate Anti‐PD‐1 Immunotherapy. Advanced Science. 12(30). e04436–e04436. 10 indexed citations
3.
Yin, Bo, et al.. (2025). Investigating the Oncogenic and Immunological Implications of YTHDF1 in Ovarian Cancer. Biologics. Volume 19. 443–462.
4.
Cui, Xu, et al.. (2025). Correlation between excessive sugar intake and overactive bladder in children. Frontiers in Pediatrics. 13. 1581852–1581852.
5.
Ji, Shuai, Yuqing Shi, & Bo Yin. (2024). Macrophage barrier in the tumor microenvironment and potential clinical applications. Cell Communication and Signaling. 22(1). 74–74. 31 indexed citations
6.
Wu, Xiaoyan, et al.. (2023). The Arabidopsis thaliana integrin-like gene AT14A improves drought tolerance in Solanum lycopersicum. Journal of Plant Research. 136(4). 563–576. 4 indexed citations
7.
Liu, Jiao, Nanqi Liu, Xuefeng Jiang, et al.. (2022). TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 175–175. 97 indexed citations
8.
Chen, Lizhu, Enchong Zhang, Jianfeng Ye, et al.. (2022). A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer. Frontiers in Medicine. 9. 832415–832415. 5 indexed citations
9.
Hu, Haoran, Sufang Wu, Bo Yin, et al.. (2022). EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression. Journal of Experimental & Clinical Cancer Research. 41(1). 165–165. 55 indexed citations
10.
Yin, Bo, et al.. (2021). FGD5 facilitates tumor growth by regulating EGFR ubiquitination in gastric cancer. Biochemical and Biophysical Research Communications. 562. 43–49. 7 indexed citations
11.
Zhao, Yongqiang, Ting Wu, Lifeng Wang, et al.. (2021). Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo. Translational Cancer Research. 10(2). 645–655. 3 indexed citations
12.
13.
14.
Bai, Xue, et al.. (2020). LASP1 induces colorectal cancer proliferation and invasiveness through Hippo signaling and Nanog mediated EMT.. PubMed. 12(10). 6490–6500. 18 indexed citations
15.
Zheng, Qianqian, Yan Li, Guang Wang, et al.. (2019). Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells. Journal of Experimental & Clinical Cancer Research. 38(1). 376–376. 67 indexed citations
16.
Li, Ming, Ying Wang, Yongsheng Song, et al.. (2015). MicroRNAs in renal cell carcinoma: A systematic review of clinical implications (Review). Oncology Reports. 33(4). 1571–1578. 63 indexed citations
17.
Kim, John J., Bo Yin, Christhunesa S. Christudass, et al.. (2012). Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer. Journal of Cellular Biochemistry. 114(6). 1286–1293. 57 indexed citations
18.
Yin, Bo, Gang Liu, Xiaosong Wang, et al.. (2011). Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 30(6). 886–892. 26 indexed citations
19.
Zeng, Yu, Steven M. Mooney, Bo Yin, et al.. (2011). Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells. Journal of Cellular Biochemistry. 112(8). 2125–2137. 24 indexed citations
20.
Mooney, Steven M., Krithika Rajagopalan, Yu Zeng, et al.. (2011). Creatine kinase brain overexpression protects colorectal cells from various metabolic and non‐metabolic stresses. Journal of Cellular Biochemistry. 112(4). 1066–1075. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susann Förster Breakdown of academic impact, for papers by Xin Song Breakdown of academic impact, for papers by Duc‐Hiep Bach Breakdown of academic impact, for papers by Xianhui Ruan Breakdown of academic impact, for papers by Haibo Han Breakdown of academic impact, for papers by Zhangqian Chen Breakdown of academic impact, for papers by Zhenjia Yu Breakdown of academic impact, for papers by Ye Song Breakdown of academic impact, for papers by Amber Willbanks Breakdown of academic impact, for papers by Junhe Li
Rankless by CCL
2026